COCA-COLA EUROPACIFIC PARTNERS Plc current report, Q2 FY2025

Business Context and Reporting Period

Company: Coca-Cola Europacific Partners Plc (CCEP)

Filing Type: Form 6-K (Report of Foreign Private Issuer)

Reporting Period: May 14, 2025 to May 20, 2025

Business Overview: CCEP is a leading consumer goods company operating in 31 countries, serving nearly 600 million consumers and over 4 million customers. The company is listed on Euronext Amsterdam, NASDAQ, London Stock Exchange, and Spanish Stock Exchanges, and is a constituent of the NASDAQ 100 and FTSE 100 indices.

Key Financial Metrics and Transactions

This filing reports on the execution of the Company's share buyback programme announced on February 14, 2025, with an aggregate authorization of up to EUR 1 billion. All repurchased shares are cancelled.

Date of Purchase US Trading Venues (Shares) London Trading Venues (Shares) Total Shares Purchased US VWAP (USD) London VWAP (GBP)
May 13, 2025 30,725 29,605 60,330 $87.75 £66.31
May 14, 2025 31,262 30,793 62,055 $86.25 £65.42
May 15, 2025 30,798 30,815 61,613 $87.54 £65.14
May 16, 2025 30,701 30,441 61,142 $87.83 £65.78
May 19, 2025 30,682 0 30,682 $88.68 N/A
Total for Period 154,168 121,654 275,822 - -

Note: No financial metrics regarding revenue, profit, cash flow, margins, debt, or liquidity are provided in this filing.

Material Changes and Operational Notes

  • Share Repurchases: The Company consistently executed buybacks across US and London venues, with the exception of May 19, 2025, where no shares were purchased on London venues.
  • Market Closure: The filing notes that no ordinary shares were purchased on London Trading Venues on May 5, 2025, due to the UK's Early May Bank Holiday.
  • Counterparty: All transactions were executed via Goldman Sachs & Co. LLC, Goldman Sachs International, or their affiliates.

Guidance, Outlook, and Risks

Buyback Programme Status: The transactions reported are part of the ongoing EUR 1 billion share buyback programme. The filing does not provide updated financial guidance, outlook, or specific risk factors beyond standard regulatory disclaimers.

Unusual Items: The filing contains no unusual items or contingencies. It is a routine disclosure of share transactions pursuant to the Market Abuse Regulation.

Key Facts for Investor Verification

  • Programme Authorization: Verify the remaining balance of the EUR 1 billion buyback authorization against the cumulative spend since February 14, 2025.
  • Share Count Impact: Confirm the reduction in total outstanding shares resulting from the cancellation of 275,822 shares during this week.
  • Trading Venues: Note the shift in activity on May 19, 2025, where all purchases were concentrated on US Trading Venues with zero activity on London venues.
  • Price Volatility: Monitor the Volume Weighted Average Price (VWAP) fluctuations, which ranged from approximately $86.25 to $88.68 on US venues during the period.